Tower Research Capital LLC (TRC) - HILLEVAX INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$34,136
-16.8%
2,538
+6.3%
0.00%0.0%
Q2 2023$41,049
+95362.8%
2,388
-7.7%
0.00%0.0%
Q1 2023$43
+53.6%
2,587
+57.4%
0.00%0.0%
Q4 2022$28
-99.7%
1,644
+174.5%
0.00%
Q3 2022$10,000
-61.5%
599
-74.7%
0.00%
-100.0%
Q2 2022$26,0002,3720.00%
Other shareholders
HILLEVAX INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$7,517,5149.98%
Frazier Life Sciences Management, L.P. 9,781,472$131,560,7988.74%
Samsara BioCapital, LLC 799,274$10,750,2353.29%
VR Adviser, LLC 2,037,313$27,401,8602.88%
StepStone Group LP 826,567$11,117,3262.48%
ACUTA CAPITAL PARTNERS, LLC 270,319$3,635,7912.44%
Deep Track Capital, LP 2,900,000$39,005,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,004,231$53,856,9071.19%
Carlyle Group Inc. 1,838,486$24,690,8671.07%
Monashee Investment Management LLC 110,000$1,479,5000.62%
View complete list of HILLEVAX INC shareholders